◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

BIO GREEN MED SOLUTION, INC.

CIK: 1130166 SIC: 2834
-
Revenue
$-5.44M
Net Income
-
Gross Margin
-
Op. Margin
$-13.64M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 11 of 44 quarterly reports available
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2023
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q1 2023
(Mar 31, 2023)
Q3 2022
(Sep 30, 2022)
+ Total Revenue $81.00K - - - $10.00K $373.00K $29.00K $31.00K $16.00K - -
Revenue Growth % (YoY) 710.0% nan% nan% -100.0% -37.5% nan% nan% nan% nan% nan% nan%
Cost of Revenue $64.00K - - - - - - - - - -
+ Gross Profit $17.00K - - - - - - - - - -
Gross Margin % 21.0% nan% nan% nan% nan% nan% nan% nan% nan% nan% nan%
Operating Expenses $1.07M $1.32M $5.04M $1.83M $2.19M $6.30M $4.38M $5.39M $6.86M $7.32M $6.47M
Research & Development $5.00K $68.00K $822.00K $880.00K $950.00K $4.73M $2.80M $3.52M $5.24M $5.67M $4.41M
Selling General & Admin - - - $948.00K $1.24M $1.57M $1.58M $1.87M $1.62M $1.65M $2.05M
+ Operating Income $-992.00K $-1.32M $-5.04M $-1.83M $-2.18M $-5.93M $-4.36M $-5.36M $-6.84M $-7.32M $-6.47M
Operating Margin % -1224.7% nan% nan% nan% -21770.0% -1589.5% -15017.2% -17290.3% -42781.2% nan% nan%
Interest Expense $6.00K $5.00K $4.00K - - - - - - - -
Interest Income - - - - - $77.00K $2.00K $23.00K $50.00K $116.00K $67.00K
Other Income/Expense $9.00K $2.00K $10.00K - $52.00K $-106.00K $52.00K - $-9.00K $195.00K $357.00K
Income Before Tax $-988.00K $-1.32M $-81.00K $-1.86M $-2.17M $-6.03M $-4.30M $-5.69M $-6.70M $-7.12M $-6.11M
Income Tax Expense - $2.00K - $1.19M $-210.00K $-586.00K $-1.35M $-422.00K $-668.00K $-1.32M $-1.01M
+ Net Income $-988.00K $-1.32M $-81.00K $-3.05M $-1.96M $-5.45M $-2.95M $-5.27M $-6.03M $-5.80M $-5.10M
Net Margin % -1219.8% nan% nan% nan% -19570.0% -1460.6% -10158.6% -17003.2% -37700.0% nan% nan%
Basic EPS -1.31 -0.98 0.00 487.92 nan -0.44 nan nan nan -0.47 -0.42
Diluted EPS -1.31 -0.98 0.00 487.92 nan -0.44 -2.27 nan nan -0.47 -0.42
Basic Shares Outstanding 1.9M - - - - 12.6M - - - 12.5M 12.3M
Diluted Shares Outstanding 1.9M - - - - 12.6M - - - 12.5M 12.3M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2023
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q1 2023
(Mar 31, 2023)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $3.84M $4.28M $3.45M $3.14M $2.98M $10.16M $2.80M $3.38M $5.94M $11.44M $23.71M
Accounts Receivable $725.00K - - - - - - - - - -
Inventory $1.37M - - - - - - - - - -
Other Current Assets $513.00K $108.00K $264.00K $537.00K $1.93M $5.13M $2.04M $4.07M $5.17M $7.54M $4.21M
Total Current Assets $6.44M $4.38M $3.71M $3.67M $4.91M $15.29M $4.83M $7.44M $11.11M $18.97M $27.91M
Property Plant & Equipment $129.00K $1.00K $1.00K $3.00K $4.00K $24.00K $7.00K $9.00K $16.00K $31.00K $37.00K
Goodwill $1.57M - - - - - - - - - -
Total Assets $8.16M $4.40M $3.73M $4.09M $5.38M $16.44M $6.17M $8.80M $12.50M $22.06M $31.02M
Accounts Payable $468.00K $221.00K $114.00K $4.60M $4.13M $2.17M $5.20M $3.54M $1.57M $2.51M $983.00K
Accrued Liabilities $534.00K $539.00K $549.00K $1.67M $2.23M $4.58M $3.15M $4.62M $6.58M $4.83M $3.37M
Total Current Liabilities $1.00M $760.00K $663.00K $6.27M $6.35M $6.75M $8.35M $8.16M $8.15M $7.34M $4.35M
Total Liabilities $1.06M $770.00K $672.00K $6.27M $6.35M $6.81M $8.37M $8.20M $8.20M $7.42M $4.46M
Common Stock $3.00K $2.00K $204.00K $9.00K $2.00K $9.00K $1.00K $1.00K $12.00K $9.00K $9.00K
Retained Earnings $-444.26M $-441.78M $-440.46M $-439.49M $-436.44M $-417.41M $-431.23M $-428.28M $-423.01M $-411.96M $-398.74M
Total Stockholders Equity $7.10M $3.63M $3.06M $-2.17M $-970.00K $5.14M $-2.21M $607.00K $4.30M $10.15M $22.07M
Total Liabilities & Equity $8.16M $4.40M $3.73M $4.09M $5.38M $16.44M $6.17M $8.80M $12.50M $22.06M $31.02M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2023
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q1 2023
(Mar 31, 2023)
Q3 2022
(Sep 30, 2022)
Net Income $-988.00K $-1.32M $-81.00K $-3.05M $-1.96M $-11.25M $-2.95M $-5.27M $-17.28M $-5.80M $-5.10M
Stock-based Compensation $1.68M $1.67M $1.67M $93.00K $499.00K $760.00K $203.00K $322.00K $1.15M $401.00K $1.12M
Change in Receivables $725.00K - - - - - - - - - -
Change in Inventory $1.37M - - - - - - - - - -
Operating Cash Flow $-4.74M $-4.30M $-3.25M $-1.36M $-6.63M $-8.17M $-483.00K $-3.91M $-12.20M $-6.86M $-15.66M
Capital Expenditure - - - - - $6.00K - - $6.00K $6.00K $7.00K
Investing Cash Flow - - - - - $-6.00K - - $-6.00K $-6.00K $-7.00K
Financing Cash Flow $5.52M $5.53M $3.65M $1.61M $6.21M $-101.00K $-79.00K $999.00K $-151.00K $-50.00K $2.96M
Net Change in Cash $701.00K $1.14M $313.00K $155.00K $-396.00K $-8.18M $-580.00K $-2.57M $-12.40M $-6.91M $-12.85M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $81.00K - $81.00K -
Cost of Revenue $64.00K - $64.00K -
Operating Expenses $1.07M - $7.43M -
Research & Development $5.00K - $895.00K -
Operating Income $-992.00K - $-7.34M -
Interest Expense - - $6.00K -
Other Income/Expense $9.00K - $21.00K -
Income Before Tax $-988.00K - $-2.38M -
Income Tax Expense - - $2.00K -
Net Income $-988.00K $-3.26M $-2.39M -
Basic EPS -1.31 - -2.86 -
Diluted EPS -1.31 - -2.86 -
Basic Shares Outstanding $1.91M - $1.37M -
Diluted Shares Outstanding $1.91M - $1.37M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $3.84M $3.14M
Accounts Receivable $725.00K -
Inventory $1.37M -
Other Current Assets $513.00K $537.00K
Total Current Assets $6.44M $3.67M
Property Plant & Equipment $129.00K $3.00K
Goodwill $1.57M -
Total Assets $8.16M $4.09M
Accounts Payable $468.00K $4.60M
Accrued Liabilities $534.00K $1.67M
Total Current Liabilities $1.00M $6.27M
Total Liabilities $1.06M $6.27M
Common Stock $3.00K -
Retained Earnings $-444.26M $-439.49M
Total Stockholders Equity $7.10M $-2.17M
Total Liabilities & Equity $8.16M $4.09M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-988.00K $-3.26M $-2.39M -
Stock-based Compensation - - $1.68M -
Change in Receivables - - $725.00K -
Change in Inventory - - $1.37M -
Operating Cash Flow - - $-4.74M -
Investing Cash Flow - - - -
Financing Cash Flow - - $5.52M -
Net Change in Cash - - $701.00K -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading news...
TRENDING
Loading...